Calidi Biotherapeutics Has Been Granted U.S. Patent Number 12,036,278 Titled "Smallpox Vaccine For Cancer Treatment".
Portfolio Pulse from Benzinga Newsdesk
Calidi Biotherapeutics has been granted U.S. Patent Number 12,036,278 for a smallpox vaccine used in cancer treatment.
July 16, 2024 | 3:19 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Calidi Biotherapeutics has received a U.S. patent for a smallpox vaccine used in cancer treatment, which could enhance its product portfolio and market position.
The granting of a patent for a novel cancer treatment method is a significant milestone for Calidi Biotherapeutics. This could lead to increased investor confidence and potential market expansion.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100